With a market cap of has a large market cap size. Illumina Inc. (NASDAQ: ILMN) has been on the stock market since its IPO date on the 7/28/2000. Illumina Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Illumina Inc., is 1451.77, and so far today it has a volume of 0. Performance year to date since the 7/28/2000 is -22.38%.
To help you determine whether Illumina Inc. is undervalued the following values will help you decide. P/E is 53.57 and forward P/E is 37.39. PEG perhaps more useful shows that Illumina Inc. has a value for PEG of 3.39. P/S ratio is 9.65 and the P/B ratio is 10.99. The P/Cash and P/Free cash flow is 16.19 and 46.02 respectively.
At the current price Illumina Inc. is trading at, 148.99 (0.00% today), Illumina Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 2.78, and this is looking to grow in the next year to 18.07% after growing 30.50% this past year. EPS growth quarter over quarter is -34.30%, and 6.20% for sales growth quarter over quarter.
The number of shares outstanding is 145.96, and the number of shares float is 145.7. The senior management bring insider ownership to 1.20%, and institutional ownership is at 96.70%. The float short is 4.73%, with the short ratio at a value of 4.75. Management has seen a return on assets of 11.10%, and also a return on investment of 16.60%.
The ability for Illumina Inc., to deal with debt, means it current ratio is 4.3, and quick ratio is 3.7. Long term debt/equity is 0.51 and total debt/equity is 0.51. In terms of margins, Illumina Inc. has a gross margin of 69.70%, with its operating margin at 24.80%, and Illumina Inc. has a profit margin of 18.40%.
The 52 week high is -38.53%, with 17.22% being its 52 week low. The 20 day simple moving average is 5.95% and the 200 day simple moving average is -4.58%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.